SCHEDULE 13G/A
Statement of Beneficial Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001831942-26-000051
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Commodore Capital LP | 1,690,014 | 3.7% |
| Commodore Capital Master LP | 1,690,014 | 3.7% |
| Robert Egen Atkinson | 1,690,014 | 3.7% |
| Michael Kramarz | 1,690,014 | 3.7% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…